top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
IL-1 Inhibition
IL-1 Inhibition
Autore Oliviero Francesca
Pubbl/distr/stampa Frontiers Media SA, 2019
Descrizione fisica 1 electronic resource (217 p.)
Soggetto topico Science: general issues
Pharmacology
Soggetto non controllato Interleukin-1
Interleukin-1 receptor antagonist
anti-interleukin-1 monoclonal antibody
Inflammasomes
Chronic inflammatory diseases
Autoinflammatory diseases
Arthritis
Osteoathritis
Skin Diseases
crystal-induced inflammation
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557475303321
Oliviero Francesca  
Frontiers Media SA, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Paediatric Formulation: Design and Development
Paediatric Formulation: Design and Development
Autore Denora Nunzio
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (205 p.)
Soggetto topico Medicine
Soggetto non controllato dasatinib
Duchenne muscular dystrophy
cyclodextrin inclusion complex
phase solubility studies
paediatric age
liquid formulation
tumorspheres
retinoblastoma
topotecan
penetration
confocal microscopy
poorly water soluble drug
solubility enhancement
grinding
spray congealing
neglected tropical diseases
polymorph
Norvir®
ritonavir
poorly soluble compound
pediatric
palatability assessment
bioavailability
flavor profile
Interleukin-1
anakinra
canakinumab
innovative biotechnologies
autoinflammatory disease
Kawasaki disease
systemic juvenile idiopathic arthritis
personalized medicine
child
pediatrics
neonates
formulation
product development
formulation development
oral
parenteral
topical
inhaled
intra nasal
biopharmaceutics
administration
excipient
NICU
device
medication error
dosage form
modified release
drug delivery
paediatric formulation development
paediatric dosage forms
chronic myeloid leukemia
tyrosine kinase inhibitors
pediatric age
imatinib
nilotinb
ponatinib
Orodispersible formulation
pyrazinamide
pediatric drug delivery
tuberculosis
design of experiments
children
edible films
development
design
paediatric
age-related
palatable
taste-masking
acceptable
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Paediatric Formulation
Record Nr. UNINA-9910557304003321
Denora Nunzio  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Systemic Autoinflammatory Diseases-Clinical Rheumatic Challenges
Systemic Autoinflammatory Diseases-Clinical Rheumatic Challenges
Autore Feist Eugen
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (266 p.)
Soggetto topico Medicine
Soggetto non controllato gout
febuxostat
colchicine
hepatotoxicity
prophylaxis
myositis
inflammatory idiopathic myopathy
dysphagia
aspiration
pneumonia
immunoglobulin G4-related orbital disease (IgG4-ROD)
orbital lymphoma (OL)
computed tomography (CT)
Hounsfield unit
imaging
autoinflammation
arthritis
CAPS
FCAS
MWS
CINCA
NOMID
hearing loss
urticarial-like rash
autoinflammatory disease
anti-IL-1 treatment
rheumatoid arthritis
synovitis
neoplasms
edema
inflammation
new genetic variant
monogenic autoinflammatory syndrome
diagnostic delay
anakinra
damage index
genetic inheritance
personalized therapy
Interleukin-1
autoinflammatory diseases
FMF
coronavirus
SARS-CoV-2 antibody response
adult-onset Still's disease
autoinflammatory disorder
systemic-onset juvenile idiopathic arthritis
haemophagocytic lymphohistiocytosis
macrophage activation syndrome
IFN-γ
JAK inhibitor
proliferation
DNA damage repair
γH2AX
PBMCs
T lymphocytes
proteasome
autoimmune
proteasome-associated autoinflammatory syndrome
therapy
IL-1 inhibitors
NGS
SURF
spondyloarthritis
human leukocyte antigen
undifferentiated enthesitis and/or arthritis
ASAS classification criteria
clinical management
canakinumab
cytokines
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557349503321
Feist Eugen  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui